High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§

被引:0
作者
Sven Macholl
Ciara M. Finucane
Jacob Hesterman
Stephen J. Mather
Rachel Pauplis
Deirdre Scully
Jane K. Sosabowski
Erwan Jouannot
机构
[1] inviCRO Ltd,Centre for Molecular Oncology, Barts Cancer Institute
[2] inviCRO,undefined
[3] LLC,undefined
[4] Queen Mary University of London,undefined
[5] Sanofi Aventis Recherche Développement,undefined
来源
EJNMMI Research | / 7卷
关键词
Nuclear imaging; Automation; Image analysis; Compound screening; Biodistribution; Pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 94 条
[1]  
Lanao JM(2005)Drug tissue distribution: study methods and therapeutic implications Curr Pharm Des 11 3829-3845
[2]  
Fraile MA(2014)EANM guideline for the preparation of an investigational medicinal product dossier (IMPD) Eur J Nucl Med Mol Imaging 41 2175-2185
[3]  
Todde S(2012)Use of radioactive compounds and autoradiography to determine drug tissue distribution Chem Res Toxicol 25 543-555
[4]  
Windhorst AD(2015)Mass spectrometry imaging in drug development Anal Chem 87 1437-1455
[5]  
Behe M(2012)Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies Chem Res Toxicol 25 532-542
[6]  
Bormans G(2004)The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines IDrugs Investig Drugs J 7 755-763
[7]  
Decristoforo C(2006)Preclinical pharmacokinetics: an approach towards safer and efficacious drugs Curr Drug Metab 7 165-182
[8]  
Faivre-Chauvet A(2009)In vivo optical imaging: preclinical applications and considerations Urol Oncol Semin Orig Investig 27 295-297
[9]  
Solon EG(2011)In vivo optical imaging and dynamic contrast methods for biomedical research Philos Trans R Soc Math Phys Eng Sci 369 4620-4643
[10]  
Nilsson A(2007)Justifying the number of animals for each experiment Nucl Med Biol 34 229-232